1. Meitinger, Franz, Ohta, Midori, Lee, Kian-Yong, Desai, Arshad, Oegema, Karen. 2020. TRIM37 controls cancer-specific vulnerability to PLK4 inhibition. In Nature, 585, 440-446. doi:10.1038/s41586-020-2710-1. https://pubmed.ncbi.nlm.nih.gov/32908304/
2. Gu, Wangpeng, Zhang, Jia, Li, Qing, Li, Jinsong, Sun, Bing. 2023. The TRIM37 variants in Mulibrey nanism patients paralyze follicular helper T cell differentiation. In Cell discovery, 9, 82. doi:10.1038/s41421-023-00561-z. https://pubmed.ncbi.nlm.nih.gov/37528081/
3. Kallijärvi, Jukka, Avela, Kristiina, Lipsanen-Nyman, Marita, Ulmanen, Ismo, Lehesjoki, Anna-Elina. 2002. The TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: classification of mulibrey nanism as a new peroxisomal disorder. In American journal of human genetics, 70, 1215-28. doi:. https://pubmed.ncbi.nlm.nih.gov/11938494/
4. Hämäläinen, Riikka H, Avela, Kristiina, Lambert, Julie A, Lipsanen-Nyman, Marita, Lehesjoki, Anna-Elina. . Novel mutations in the TRIM37 gene in Mulibrey Nanism. In Human mutation, 23, 522. doi:. https://pubmed.ncbi.nlm.nih.gov/15108285/
5. Hu, Cheng-En, Gan, Jun. 2017. TRIM37 promotes epithelial‑mesenchymal transition in colorectal cancer. In Molecular medicine reports, 15, 1057-1062. doi:10.3892/mmr.2017.6125. https://pubmed.ncbi.nlm.nih.gov/28098873/
6. Tao, Yanling, Xin, Meiyun, Cheng, Huanchen, Zhang, Teng, Wang, Jianlong. 2017. TRIM37 promotes tumor cell proliferation and drug resistance in pediatric osteosarcoma. In Oncology letters, 14, 6365-6372. doi:10.3892/ol.2017.7059. https://pubmed.ncbi.nlm.nih.gov/29163677/